Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,400.96
(
-0.16%
)
US TECH 100
28,196.00
(
-1.18%
)
Dow Jones
49,760.56
(
0.11%
)
Brent Oil
104.52
(
-1.17%
)
Bitcoin
81,016.41
(
0.65%
)
News Focus
News Focus
Post# of 447903
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

JRoon71

Send PM Follow Ignore
Followers 22
Posts 4688
Boards Moderated 0
Alias Born 01/27/2022

JRoon71

Re: ramfan60 post# 430384

Thursday, 11/14/2024 9:39:39 AM

Thursday, November 14, 2024 9:39:39 AM

Post# of 447903
He basically said anything related to a new formulation is in the distant future, and they are focused on Vascepa right now.

With the U.S. market, nothing noteworthy. They don't sound too enthusiastic about an AG right now, and no mention of anything on the legal front.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AMRN News
More AMRN News